Sept 14 (Reuters) - Canopy Growth Corp launched its first-ever cannabidiol (CBD) vape 'Whisl' in the United States on Tuesday, pinterest cricket bets online 44.30780915722572 18100 0.209178 16 14400000 betting online cricket 43.35385198409238 18100 0.209178 16 34800000 pinterest on rising demand for alternatives to tobacco and cigarettes.

The U.S.

e-cigarette and vape market was valued at $15 billion last year and a "growing emphasis on adopting safer alternatives to smoking" is expected to drive 28% annual growth through 2028, according to Grand View Research.

CBD, a non-psychoactive compound derived mainly from the hemp variant of cannabis, saw a massive rise in popularity last year as more people turned to it for relaxation during the months-long isolation caused by COVID-19, lifting sales of pot producers.

Canopy has looked to capitalize on the increased demand and launched various products such as CBD-infused beverage line in Canada and the United States and even a new line of cannabis-infused soft chews and drops for dogs.

Canopy said its Whisl pods will be available in three variants, each targeting mood management during different parts of a day.

Each pod will contain 200 milligram of a purified form of CBD, sourced from licensed hemp providers within the United States.

Canopy said its nicotine-free vaporizer will be available in more than 3,000 Circle K convenience stores in 21 states from Oct. 1.
(Reporting by Sahil Shaw in Bengaluru; Editing by Maju Samuel)